PXS.L

Provexis plc [PXS.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PXS.L Stock Summary

Top 10 Correlated ETFs

PXS.L

Top 10 Correlated Stocks

PXS.L

In the News

PXS.L Financial details

Company Rating
-
Market Cap
15.56M
Income
-746.43K
Revenue
992.42K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
27 Sep 2024
P/E
-40.28
Forward P/E
-
PEG
-2.01
P/S
44.65
P/B
13.05
P/C
-
P/FCF
-33.43
Quick Ratio
2.01
Current Ratio
4.49
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
100%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-7.79%
Revenue last 5Y
3.89%
Revenue Q/Q
84.06%
EPS Q/Q
-
-
-
-
-
SMA20
45.61%
SMA50
48.21%
SMA100
33.87%
Inst Own
-
Inst Trans
-
ROA
-46%
ROE
-29%
ROC
-0.64%
Gross Margin
76%
Oper. Margin
-108%
Profit Margin
-99%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.413-0.9
52W High
-
52W Low
-
RSI
61.19
Rel Volume
0.85
Avg Volume
818.86K
Volume
697.95K
Perf Week
-13.89%
Perf Month
55.78%
Perf Quarter
19.23%
Perf Half Y
19.23%
-
-
-
-
Beta
1.19
-
-
Volatility
0.04%, 0.12%
Prev Close
0%
Price
0.775
Change
2.65%

Something similar

Top by Market Cap
AMZ.DE
FXAIX
3V64.DE
JPM
MSFT
Top Correlated ETFs
BYBU.L
EMDD.L
EMLB.L
EMLC.L
BCHN.L
Top Correlated Stocks
LAURUSLABS.NS
ALDRV.PA
KARURVYSYA.NS
MMP.NS
COM.L
Similar Market Cap
HDAW
PSFJ
XTLB
WWAC
LLL

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 818.86K
  • Market Capitalization 15.56M
  • Employee 2
  • CEO Mr. Ian Ford BA (Hons) ACA, F.C.A.
  • Headquarters Reading,GB
  • IPO Date 2004-06-28
  • Website https://www.provexis.com

Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.